Artemis Investment Management LLP United Therapeutics Corp Transaction History

Artemis Investment Management LLP

  • $6.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
$184.32 - $216.08 $1.38 Million - $1.62 Million
-7,502 Closed
0 $0
Q3 2021

Oct 26, 2021
SELL
$179.86 - $214.88 $105,757 - $126,349
-588 Reduced 7.27%
7,502 $1.39 Million
Q2 2021

Aug 04, 2021
BUY
$170.47 - $211.93 $1.38 Million - $1.71 Million
8,090 New
8,090 $1.45 Million

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.4M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email